Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant - PA: MSK, Skin and Oral Health: Clinical Research - MSK Health

University of Ottawa

$100,000.00

Identification of molecular mechanisms involved in the biological response to implant wear and corrosion

FY 2017-18

Summary
Estimates predict the number of 45- to 54-year-old people diagnosed with osteoarthritis (OA) will double from 1991 to 2031. With Canada's aging population and the dramatic rise in OA, the demand for total joint replacements will continue to grow, and so will the need to improve implant longevity. Importantly, patients are expected to return to an active lifestyle, which adds to the longevity requirements of joint replacements. Consequently, improving implant longevity has been an important focus of medical research and industrial R&D. Particles and metal ions from implant wear and corrosion are known to be a major contributing factor to adverse biological reactions and implant failures. It is therefore important to better understand and modulate the biological effects of implant wear particles and metal ions to prolong implant life. Our research focuses on the identification of the molecular mechanisms involved in the biological response to implant wear particles and metal ions. The proposed multidisciplinary research, at the interface of biology, medicine, materials science and engineering, will expand our knowledge of implant failure mechanisms and ultimately lead to the development of new therapeutic approaches to modulate the adverse effects of implant wear particles and metal ions, and thereby increase implant longevity. Therefore, this research has the potential to improve the quality of life for large patient groups and provide tangible benefits to the Canadian health care system.
Program
Project Grant - PA: MSK, Skin and Oral Health: Clinical Research - MSK Health
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
385245
Name
Catelas Isabelle
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Biomedical Engineering
Projecttitle
Identification of molecular mechanisms involved in the biological response to implant wear and corrosion
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: MSK, Skin and Oral Health: Clinical Research - MSK Health
Keyworddelim
Animal Models; Biomaterials; Cell Culture; Implants; Inflammatory Response; Medical Devices; Metal Ions; Molecular Mechanisms; Wear Particles
Abstract
Estimates predict the number of 45- to 54-year-old people diagnosed with osteoarthritis (OA) will double from 1991 to 2031. With Canada's aging population and the dramatic rise in OA, the demand for total joint replacements will continue to grow, and so will the need to improve implant longevity. Importantly, patients are expected to return to an active lifestyle, which adds to the longevity requirements of joint replacements. Consequently, improving implant longevity has been an important focus of medical research and industrial R&D. Particles and metal ions from implant wear and corrosion are known to be a major contributing factor to adverse biological reactions and implant failures. It is therefore important to better understand and modulate the biological effects of implant wear particles and metal ions to prolong implant life. Our research focuses on the identification of the molecular mechanisms involved in the biological response to implant wear particles and metal ions. The proposed multidisciplinary research, at the interface of biology, medicine, materials science and engineering, will expand our knowledge of implant failure mechanisms and ultimately lead to the development of new therapeutic approaches to modulate the adverse effects of implant wear particles and metal ions, and thereby increase implant longevity. Therefore, this research has the potential to improve the quality of life for large patient groups and provide tangible benefits to the Canadian health care system.
Competitiondate
201803
Approvedterm2
1 yr 0 mth
Pinamesdelim
Catelas, Isabelle
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
University of Ottawa - $100,000 Grant (2017-18) | Canada Spends